These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 16495773)

  • 1. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,4-diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: dual effectors on acyl-CoA:cholesterol O-acyltransferase and low-density lipoprotein receptor expression.
    Asano S; Ban H; Kino K; Ioriya K; Muraoka M
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1062-5. PubMed ID: 19167888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
    Kitayama K; Koga T; Inaba T; Fujioka T
    Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of SMP-500, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on serum cholesterol level and LDL cholesterol clearance in hamsters with induced hyperlipidemia.
    Ioriya K; Kino K; Sato YF; Ohashi N
    Pharmacology; 2002 Oct; 66(2):107-14. PubMed ID: 12207118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
    Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
    Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
    Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of fish oil and fish protein hydrolysate reduces the plasma cholesterol level with a concurrent increase in hepatic cholesterol level in high-fat-fed Wistar rats.
    Wergedahl H; Gudbrandsen OA; Røst TH; Berge RK
    Nutrition; 2009 Jan; 25(1):98-104. PubMed ID: 18752928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility.
    Ban H; Muraoka M; Ioriya K; Ohashi N
    Bioorg Med Chem Lett; 2006 Jan; 16(1):44-8. PubMed ID: 16242323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
    Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluvastatin sodium on secretion of very low density lipoprotein and serum cholesterol levels. In vivo study using low density lipoprotein receptor deficient watanabe heritable hyperlipidemic rabbits.
    Shiomi M; Shiraishi M; Yata T; Ito T
    Arzneimittelforschung; 1994 Oct; 44(10):1154-6. PubMed ID: 7818592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypolipidemic action of the ACAT inhibitor HL-004 in hamsters fed normal chow.
    Murakami S; Ohta Y; Asami Y; Yamagishi I; Toda Y; Sato M; Tomisawa K
    Gen Pharmacol; 1996 Dec; 27(8):1383-6. PubMed ID: 9304411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
    Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.
    Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets.
    Lee HT; Sliskovic DR; Picard JA; Roth BD; Wierenga W; Hicks JL; Bousley RF; Hamelehle KL; Homan R; Speyer C; Stanfield RL; Krause BR
    J Med Chem; 1996 Dec; 39(26):5031-4. PubMed ID: 8978833
    [No Abstract]   [Full Text] [Related]  

  • 20. Dietary conjugated linoleic acid mixture affects the activity of intestinal acyl coenzyme A: cholesterol acyltransferase in hamsters.
    Thomas Yeung CH; Yang L; Huang Y; Wang J; Chen ZY
    Br J Nutr; 2000 Dec; 84(6):935-41. PubMed ID: 11177212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.